Literature DB >> 9053440

CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.

P A van der Merwe1, D L Bodian, S Daenke, P Linsley, S J Davis.   

Abstract

The structurally related T cell surface molecules CD28 and CTLA-4 interact with cell surface ligands CD80 (B7-1) and CD86 (B7-2) on antigen-presenting cells (APC) and modulate T cell antigen recognition. Preliminary reports have suggested that CD80 binds CTLA-4 and CD28 with affinities (Kd values approximately 12 and approximately 200 nM, respectively) that are high when compared with other molecular interactions that contribute to T cell-APC recognition. In the present study, we use surface plasmon resonance to measure the affinity and kinetics of CD80 binding to CD28 and CTLA-4. At 37 degrees C, soluble recombinant CD80 bound to CTLA-4 and CD28 with Kd values of 0.42 and 4 microM, respectively. Kinetic analysis indicated that these low affinities were the result of very fast dissociation rate constants (k(off)); sCD80 dissociated from CD28 and CTLA-4 with k(off) values of > or = 1.6 and > or = 0.43 s-1, respectively. Such rapid binding kinetics have also been reported for the T cell adhesion molecule CD2 and may be necessary to accommodate-dynamic T cell-APC contacts and to facilitate scanning of APC for antigen.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9053440      PMCID: PMC2196039          DOI: 10.1084/jem.185.3.393

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  71 in total

1.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis.

Authors:  E R Christinck; M A Luscher; B H Barber; D B Williams
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

2.  Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system.

Authors:  R Karlsson; A Michaelsson; L Mattsson
Journal:  J Immunol Methods       Date:  1991-12-15       Impact factor: 2.303

3.  Low affinity interaction of peptide-MHC complexes with T cell receptors.

Authors:  K Matsui; J J Boniface; P A Reay; H Schild; B Fazekas de St Groth; M M Davis
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

4.  The minimal number of class II MHC-antigen complexes needed for T cell activation.

Authors:  S Demotz; H M Grey; A Sette
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

5.  CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events.

Authors:  J Nunès; S Klasen; M Ragueneau; C Pavon; D Couez; C Mawas; M Bagnasco; D Olive
Journal:  Int Immunol       Date:  1993-03       Impact factor: 4.823

6.  CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.

Authors:  I F Luescher; E Vivier; A Layer; J Mahiou; F Godeau; B Malissen; P Romero
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

7.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

8.  CTLA-4 is a second receptor for the B cell activation antigen B7.

Authors:  P S Linsley; W Brady; M Urnes; L S Grosmaire; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

9.  Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton.

Authors:  S Valitutti; M Dessing; K Aktories; H Gallati; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.

Authors:  P S Linsley; J L Greene; P Tan; J Bradshaw; J A Ledbetter; C Anasetti; N K Damle
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  160 in total

Review 1.  Function and regulation of memory CD4 T cells.

Authors:  D P Metz; K Bottomly
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2.

Authors:  Y Furukawa; D A Mandelbrot; P Libby; A H Sharpe; R N Mitchell
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 3.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 4.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 5.  Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy.

Authors:  Michael Postow; Margaret K Callahan; Jedd D Wolchok
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

6.  Interaction of CTLA-4 with AP50, a clathrin-coated pit adaptor protein.

Authors:  Y Zhang; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Authors:  J Rohr; S Guo; J Huo; A Bouska; C Lachel; Y Li; P D Simone; W Zhang; Q Gong; C Wang; A Cannon; T Heavican; A Mottok; S Hung; A Rosenwald; R Gascoyne; K Fu; T C Greiner; D D Weisenburger; J M Vose; L M Staudt; W Xiao; G E O Borgstahl; S Davis; C Steidl; T McKeithan; J Iqbal; W C Chan
Journal:  Leukemia       Date:  2015-12-31       Impact factor: 11.528

8.  Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy.

Authors:  Yu Jin Lim; Jaemoon Koh; Kyubo Kim; Eui Kyu Chie; Sehui Kim; Kyoung Bun Lee; Jin-Young Jang; Sun Whe Kim; Do-Youn Oh; Yung-Jue Bang
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

9.  Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.

Authors:  Erika Scharschmidt; Elmar Wegener; Vigo Heissmeyer; Anjana Rao; Daniel Krappmann
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Authors:  M Valés-Gómez; H T Reyburn; R A Erskine; J Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.